Switzerland could revise offer on Trump tariffs, business minister says

The U.S. has announced a substantial 39% import tariff on Switzerland, effective August 7, prompting Swiss Business Minister Guy Parmelin to signal the government's openness to revising its offer, potentially through increased U.S. liquefied natural gas purchases or investments, to avert the duties. This move has stunned Switzerland, with economists warning of a significant economic impact including a potential recession, a 0.3-0.6% reduction in Swiss GDP (potentially over 1% if pharmaceuticals are included), and tens of thousands of job losses. Consequently, Swiss shares are expected to be negatively affected, and Nomura anticipates a 25 basis point interest rate cut by the Swiss National Bank in September to counter the economic headwinds.

Analysis

The unexpected imposition of a 39% U.S. tariff on Swiss goods represents a significant macroeconomic shock for Switzerland, directly threatening its export-oriented economy. The Swiss government is actively seeking to avert the tariff before the August 7 deadline, with Business Minister Guy Parmelin indicating a willingness to revise its trade offer, potentially including increased purchases of U.S. LNG or further direct investment. The primary catalyst for the tariff appears to be the $48 billion U.S. trade deficit with Switzerland. Economists, such as Hans Gersbach from ETH Zurich, forecast a severe impact, with a potential GDP reduction of 0.3% to 0.6% and a material risk of recession; this impact could exceed 1% if the tariffs are prolonged or expanded to include pharmaceuticals. In response to the anticipated economic slowdown and deflationary pressures, financial institution Nomura forecasts that the Swiss National Bank (SNB) will likely implement a 25 basis point policy rate cut in September, bringing the rate to -0.25%. This confluence of trade-related growth shock and expected monetary easing signals a decidedly negative outlook for Swiss equities and the Swiss Franc in the near term.

Key Decisions for Investors

• Investors should anticipate significant downside pressure on the Swiss equity market, particularly for export-dependent sectors like machinery and watches, and may consider hedging or reducing exposure to Swiss indices.
• Given the high probability of a Swiss National Bank rate cut to -0.25% in September, traders could consider positioning for a weaker Swiss Franc (CHF) against major currency pairs.
• Monitor diplomatic negotiations between the U.S. and Switzerland closely, as any successful resolution before the August 7 deadline could lead to a sharp reversal in sentiment and present a short-term trading opportunity.
• The potential inclusion of pharmaceuticals, currently exempt, into the tariff list represents a key tail risk that would significantly escalate the economic damage and further negatively impact Swiss multinational pharma stocks.